Consort flow diagram.

<p>Forty-seven patients were screened; 2 patients did not meet the eligibility criteria and so 45 were enrolled onto the study. One patient was subsequently diagnosed with chronic lymphocytic leukaemia therefore only 44 patients received the first course of rituximab. A further 8 patients did not complete the study and a total of 36 patients were included in the final analysis; of these only 32 received the second RTX course.